Jim Cornall

biotech

Activating human killer T-cells against cancer

biotech

Spinal Muscular Atrophy Awareness Month begins with spotlight on care gaps

biotech

University of Aberdeen-led team to trial new drug for heavy menstrual bleeding

biotech

Bristol Myers Squibb announces $2.3bn campus in Texas

biotech

Mironid raises $46m to advance clinical development of rare kidney disease treatment

biotech

Foundation for Angelman Syndrome Therapeutics announces agreement with Apertura Gene Therapy for access to blood-brain barrier-crossing capsid

biotech

3D genome mapping in rare immune cells reveals new Crohn’s genes

biotech

Cancer cells hijack a fatty acid to escape immune attack in liver metastases